nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranexamic Acid—PLG—prostate gland—prostate cancer	0.0186	0.243	CbGeAlD
Tranexamic Acid—PLG—epithelium—prostate cancer	0.0137	0.178	CbGeAlD
Tranexamic Acid—PLG—renal system—prostate cancer	0.0127	0.165	CbGeAlD
Tranexamic Acid—PLG—testis—prostate cancer	0.00821	0.107	CbGeAlD
Tranexamic Acid—SLC15A2—prostate gland—prostate cancer	0.00596	0.0776	CbGeAlD
Tranexamic Acid—SLC15A2—seminal vesicle—prostate cancer	0.00504	0.0656	CbGeAlD
Tranexamic Acid—SLC15A2—renal system—prostate cancer	0.00406	0.0529	CbGeAlD
Tranexamic Acid—SLC15A2—urethra—prostate cancer	0.00399	0.0519	CbGeAlD
Tranexamic Acid—SLC15A2—testis—prostate cancer	0.00262	0.0342	CbGeAlD
Tranexamic Acid—SLC15A2—lymph node—prostate cancer	0.0019	0.0248	CbGeAlD
Tranexamic Acid—PLG—Metabolism of proteins—MUC4—prostate cancer	0.000516	0.00127	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—CD9—prostate cancer	0.000511	0.00126	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—prostate cancer	0.000505	0.00124	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000505	0.00124	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PDGFRB—prostate cancer	0.000504	0.00124	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000503	0.00124	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—VAV3—prostate cancer	0.000489	0.0012	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—CASP3—prostate cancer	0.00048	0.00118	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—ERBB3—prostate cancer	0.000476	0.00117	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—FGFR2—prostate cancer	0.000475	0.00117	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—ITPR1—prostate cancer	0.000475	0.00117	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—CLU—prostate cancer	0.000463	0.00114	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP9—prostate cancer	0.000454	0.00112	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—RPL12—prostate cancer	0.000451	0.00111	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000449	0.00111	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—VEGFA—prostate cancer	0.000444	0.00109	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—IL6—prostate cancer	0.00044	0.00108	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—HSP90B1—prostate cancer	0.000428	0.00105	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—GRB7—prostate cancer	0.000423	0.00104	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—VEGFA—prostate cancer	0.000423	0.00104	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—ITGB3—prostate cancer	0.00042	0.00103	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000415	0.00102	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—EIF3A—prostate cancer	0.000414	0.00102	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—AKT1—prostate cancer	0.000412	0.00102	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000411	0.00101	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—TGFB1—prostate cancer	0.000407	0.001	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—GNG5—prostate cancer	0.000402	0.000991	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000398	0.00098	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—BAD—prostate cancer	0.000397	0.000977	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—TP53—prostate cancer	0.000391	0.000963	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—PIK3CA—prostate cancer	0.00039	0.00096	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—TGFB1—prostate cancer	0.000388	0.000955	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—EGF—prostate cancer	0.00038	0.000935	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—IRS1—prostate cancer	0.00038	0.000935	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—OR51E2—prostate cancer	0.000378	0.00093	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—TP53—prostate cancer	0.000377	0.000929	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—GSK3B—prostate cancer	0.000369	0.000908	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—MME—prostate cancer	0.000368	0.000906	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000366	0.000902	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—ITGB3—prostate cancer	0.000364	0.000897	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—IL6—prostate cancer	0.000358	0.000881	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—GRP—prostate cancer	0.000352	0.000868	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000348	0.000858	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—BMPR1B—prostate cancer	0.000345	0.00085	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PRKACB—prostate cancer	0.000343	0.000845	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—RPL10—prostate cancer	0.000342	0.000842	CbGpPWpGaD
Tranexamic Acid—Haemoglobin—Capecitabine—prostate cancer	0.000341	0.00066	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Etoposide—prostate cancer	0.000341	0.000659	CcSEcCtD
Tranexamic Acid—Dyspepsia—Estradiol—prostate cancer	0.000341	0.000659	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—MAP2K1—prostate cancer	0.00034	0.000837	CbGpPWpGaD
Tranexamic Acid—Haemorrhage—Capecitabine—prostate cancer	0.00034	0.000657	CcSEcCtD
Tranexamic Acid—Anaemia—Etoposide—prostate cancer	0.00034	0.000657	CcSEcCtD
Tranexamic Acid—Visual impairment—Docetaxel—prostate cancer	0.000338	0.000654	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CD—prostate cancer	0.000338	0.000832	CbGpPWpGaD
Tranexamic Acid—Hypotension—Mitoxantrone—prostate cancer	0.000337	0.000652	CcSEcCtD
Tranexamic Acid—Migraine—Epirubicin—prostate cancer	0.000337	0.000651	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—THBS1—prostate cancer	0.000334	0.000823	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Estradiol—prostate cancer	0.000334	0.000646	CcSEcCtD
Tranexamic Acid—Diarrhoea—Goserelin—prostate cancer	0.000334	0.000646	CcSEcCtD
Tranexamic Acid—Fatigue—Estradiol—prostate cancer	0.000334	0.000645	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Prednisone—prostate cancer	0.000332	0.000643	CcSEcCtD
Tranexamic Acid—Malaise—Etoposide—prostate cancer	0.000331	0.000641	CcSEcCtD
Tranexamic Acid—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000331	0.00064	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Prednisone—prostate cancer	0.00033	0.000639	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CG—prostate cancer	0.000329	0.00081	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000328	0.000635	CcSEcCtD
Tranexamic Acid—Eye disorder—Docetaxel—prostate cancer	0.000328	0.000634	CcSEcCtD
Tranexamic Acid—Visual impairment—Capecitabine—prostate cancer	0.000327	0.000633	CcSEcCtD
Tranexamic Acid—Anaphylactoid reaction—Doxorubicin—prostate cancer	0.000327	0.000632	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Docetaxel—prostate cancer	0.000326	0.00063	CcSEcCtD
Tranexamic Acid—Flushing—Docetaxel—prostate cancer	0.000326	0.00063	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—EGF—prostate cancer	0.000325	0.000801	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000324	0.000799	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—FGF2—prostate cancer	0.000324	0.000797	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PRKCZ—prostate cancer	0.000324	0.000796	CbGpPWpGaD
Tranexamic Acid—Loss of consciousness—Etoposide—prostate cancer	0.000323	0.000625	CcSEcCtD
Tranexamic Acid—Cerebrovascular accident—Doxorubicin—prostate cancer	0.000323	0.000625	CcSEcCtD
Tranexamic Acid—Dizziness—Goserelin—prostate cancer	0.000323	0.000624	CcSEcCtD
Tranexamic Acid—Dyspnoea—Mitoxantrone—prostate cancer	0.000321	0.000622	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—RGS17—prostate cancer	0.000321	0.000791	CbGpPWpGaD
Tranexamic Acid—Dizziness—Conjugated Estrogens—prostate cancer	0.00032	0.000618	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Estradiol—prostate cancer	0.000319	0.000617	CcSEcCtD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—AKT1—prostate cancer	0.000319	0.000785	CbGpPWpGaD
Tranexamic Acid—Convulsion—Etoposide—prostate cancer	0.000318	0.000616	CcSEcCtD
Tranexamic Acid—Angiopathy—Docetaxel—prostate cancer	0.000318	0.000616	CcSEcCtD
Tranexamic Acid—Eye disorder—Capecitabine—prostate cancer	0.000317	0.000614	CcSEcCtD
Tranexamic Acid—Dyspepsia—Mitoxantrone—prostate cancer	0.000317	0.000614	CcSEcCtD
Tranexamic Acid—Immune system disorder—Docetaxel—prostate cancer	0.000317	0.000613	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Estradiol—prostate cancer	0.000316	0.000612	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Docetaxel—prostate cancer	0.000316	0.000611	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000316	0.000778	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000316	0.000778	CbGpPWpGaD
Tranexamic Acid—Flushing—Capecitabine—prostate cancer	0.000315	0.00061	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Capecitabine—prostate cancer	0.000315	0.00061	CcSEcCtD
Tranexamic Acid—Arrhythmia—Docetaxel—prostate cancer	0.000313	0.000606	CcSEcCtD
Tranexamic Acid—Chest pain—Etoposide—prostate cancer	0.000313	0.000605	CcSEcCtD
Tranexamic Acid—Migraine—Doxorubicin—prostate cancer	0.000311	0.000602	CcSEcCtD
Tranexamic Acid—Fatigue—Mitoxantrone—prostate cancer	0.000311	0.000601	CcSEcCtD
Tranexamic Acid—Vomiting—Goserelin—prostate cancer	0.00031	0.0006	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—JAK2—prostate cancer	0.00031	0.000764	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—KDR—prostate cancer	0.00031	0.000763	CbGpPWpGaD
Tranexamic Acid—Discomfort—Etoposide—prostate cancer	0.000309	0.000598	CcSEcCtD
Tranexamic Acid—Angiopathy—Capecitabine—prostate cancer	0.000308	0.000596	CcSEcCtD
Tranexamic Acid—Vomiting—Conjugated Estrogens—prostate cancer	0.000307	0.000595	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—ATF3—prostate cancer	0.000307	0.000756	CbGpPWpGaD
Tranexamic Acid—Immune system disorder—Capecitabine—prostate cancer	0.000307	0.000593	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Capecitabine—prostate cancer	0.000306	0.000592	CcSEcCtD
Tranexamic Acid—Abdominal pain—Estradiol—prostate cancer	0.000306	0.000592	CcSEcCtD
Tranexamic Acid—Headache—Goserelin—prostate cancer	0.000306	0.000591	CcSEcCtD
Tranexamic Acid—Haemoglobin—Prednisone—prostate cancer	0.000304	0.000588	CcSEcCtD
Tranexamic Acid—Arrhythmia—Capecitabine—prostate cancer	0.000303	0.000587	CcSEcCtD
Tranexamic Acid—Headache—Conjugated Estrogens—prostate cancer	0.000303	0.000586	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—MDM2—prostate cancer	0.000303	0.000745	CbGpPWpGaD
Tranexamic Acid—Haemorrhage—Prednisone—prostate cancer	0.000303	0.000585	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—IGF1—prostate cancer	0.000301	0.000742	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.0003	0.000739	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Etoposide—prostate cancer	0.0003	0.00058	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—ERBB2—prostate cancer	0.000298	0.000735	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—ICAM1—prostate cancer	0.000297	0.000731	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Mitoxantrone—prostate cancer	0.000297	0.000575	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000297	0.000731	CbGpPWpGaD
Tranexamic Acid—Back pain—Docetaxel—prostate cancer	0.000295	0.000571	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000295	0.00057	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CB—prostate cancer	0.000295	0.000725	CbGpPWpGaD
Tranexamic Acid—Muscle spasms—Docetaxel—prostate cancer	0.000294	0.000568	CcSEcCtD
Tranexamic Acid—Nausea—Goserelin—prostate cancer	0.00029	0.000561	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CD—prostate cancer	0.000289	0.000712	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—IGFBP3—prostate cancer	0.000289	0.000712	CbGpPWpGaD
Tranexamic Acid—Angina pectoris—Epirubicin—prostate cancer	0.000288	0.000557	CcSEcCtD
Tranexamic Acid—Nausea—Conjugated Estrogens—prostate cancer	0.000287	0.000555	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—RLN2—prostate cancer	0.000286	0.000705	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SERPINE1—prostate cancer	0.000286	0.000704	CbGpPWpGaD
Tranexamic Acid—Back pain—Capecitabine—prostate cancer	0.000286	0.000553	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Estradiol—prostate cancer	0.000285	0.000551	CcSEcCtD
Tranexamic Acid—Abdominal pain—Mitoxantrone—prostate cancer	0.000285	0.000551	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IL6—prostate cancer	0.000284	0.0007	CbGpPWpGaD
Tranexamic Acid—Muscle spasms—Capecitabine—prostate cancer	0.000284	0.00055	CcSEcCtD
Tranexamic Acid—Eye disorder—Prednisone—prostate cancer	0.000283	0.000547	CcSEcCtD
Tranexamic Acid—Anaemia—Docetaxel—prostate cancer	0.000282	0.000546	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—ACHE—prostate cancer	0.000282	0.000695	CbGpPWpGaD
Tranexamic Acid—Flushing—Prednisone—prostate cancer	0.000281	0.000543	CcSEcCtD
Tranexamic Acid—Hypotension—Etoposide—prostate cancer	0.00028	0.000542	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.00028	0.000689	CbGpPWpGaD
Tranexamic Acid—Asthenia—Estradiol—prostate cancer	0.000278	0.000537	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—CDKN1B—prostate cancer	0.000276	0.000681	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PRKCQ—prostate cancer	0.000275	0.000677	CbGpPWpGaD
Tranexamic Acid—Angiopathy—Prednisone—prostate cancer	0.000274	0.000531	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Capecitabine—prostate cancer	0.000274	0.000531	CcSEcCtD
Tranexamic Acid—Anaemia—Capecitabine—prostate cancer	0.000273	0.000529	CcSEcCtD
Tranexamic Acid—Immune system disorder—Prednisone—prostate cancer	0.000273	0.000529	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—HSD17B1—prostate cancer	0.000273	0.000672	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CTBP2—prostate cancer	0.000273	0.000672	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PLAUR—prostate cancer	0.000272	0.000669	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—RPS19—prostate cancer	0.000271	0.000668	CbGpPWpGaD
Tranexamic Acid—Arrhythmia—Prednisone—prostate cancer	0.00027	0.000523	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Docetaxel—prostate cancer	0.000268	0.000519	CcSEcCtD
Tranexamic Acid—Dyspnoea—Etoposide—prostate cancer	0.000267	0.000517	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000267	0.000658	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CTSD—prostate cancer	0.000267	0.000658	CbGpPWpGaD
Tranexamic Acid—Malaise—Capecitabine—prostate cancer	0.000267	0.000516	CcSEcCtD
Tranexamic Acid—Angina pectoris—Doxorubicin—prostate cancer	0.000266	0.000515	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Mitoxantrone—prostate cancer	0.000266	0.000514	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—JAK2—prostate cancer	0.000266	0.000654	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Estradiol—prostate cancer	0.000265	0.000512	CcSEcCtD
Tranexamic Acid—Convulsion—Docetaxel—prostate cancer	0.000265	0.000512	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—THBS1—prostate cancer	0.000263	0.000648	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—CDH1—prostate cancer	0.000263	0.000647	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PLXNB1—prostate cancer	0.000262	0.000644	CbGpPWpGaD
Tranexamic Acid—Myalgia—Docetaxel—prostate cancer	0.00026	0.000503	CcSEcCtD
Tranexamic Acid—Chest pain—Docetaxel—prostate cancer	0.00026	0.000503	CcSEcCtD
Tranexamic Acid—Arthralgia—Docetaxel—prostate cancer	0.00026	0.000503	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Capecitabine—prostate cancer	0.00026	0.000503	CcSEcCtD
Tranexamic Acid—Renal failure—Epirubicin—prostate cancer	0.000259	0.000501	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Etoposide—prostate cancer	0.000259	0.000501	CcSEcCtD
Tranexamic Acid—Asthenia—Mitoxantrone—prostate cancer	0.000259	0.0005	CcSEcCtD
Tranexamic Acid—Fatigue—Etoposide—prostate cancer	0.000259	0.0005	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000256	0.000631	CbGpPWpGaD
Tranexamic Acid—Dizziness—Estradiol—prostate cancer	0.000256	0.000495	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—CDKN1A—prostate cancer	0.000255	0.000628	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PTEN—prostate cancer	0.000255	0.000627	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP2—prostate cancer	0.000253	0.000623	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—VAV3—prostate cancer	0.000252	0.000621	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CB—prostate cancer	0.000252	0.000621	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GRPR—prostate cancer	0.000252	0.00062	CbGpPWpGaD
Tranexamic Acid—Chest pain—Capecitabine—prostate cancer	0.000252	0.000487	CcSEcCtD
Tranexamic Acid—Myalgia—Capecitabine—prostate cancer	0.000252	0.000487	CcSEcCtD
Tranexamic Acid—Arthralgia—Capecitabine—prostate cancer	0.000252	0.000487	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—CALR—prostate cancer	0.00025	0.000616	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Docetaxel—prostate cancer	0.000249	0.000482	CcSEcCtD
Tranexamic Acid—Discomfort—Capecitabine—prostate cancer	0.000249	0.000481	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—SERPINE1—prostate cancer	0.000248	0.000611	CbGpPWpGaD
Tranexamic Acid—Sinusitis—Epirubicin—prostate cancer	0.000247	0.000478	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Etoposide—prostate cancer	0.000247	0.000478	CcSEcCtD
Tranexamic Acid—Diarrhoea—Mitoxantrone—prostate cancer	0.000247	0.000477	CcSEcCtD
Tranexamic Acid—Vomiting—Estradiol—prostate cancer	0.000246	0.000476	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Etoposide—prostate cancer	0.000245	0.000474	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—ITPR1—prostate cancer	0.000245	0.000602	CbGpPWpGaD
Tranexamic Acid—Nervous system disorder—Docetaxel—prostate cancer	0.000244	0.000473	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Prednisone—prostate cancer	0.000244	0.000473	CcSEcCtD
Tranexamic Acid—Anaemia—Prednisone—prostate cancer	0.000243	0.000471	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—IL17RD—prostate cancer	0.000243	0.000599	CbGpPWpGaD
Tranexamic Acid—Headache—Estradiol—prostate cancer	0.000242	0.000469	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—FGF2—prostate cancer	0.00024	0.000592	CbGpPWpGaD
Tranexamic Acid—Renal failure—Doxorubicin—prostate cancer	0.00024	0.000464	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—ACE—prostate cancer	0.000238	0.000586	CbGpPWpGaD
Tranexamic Acid—Haemoglobin—Epirubicin—prostate cancer	0.000238	0.00046	CcSEcCtD
Tranexamic Acid—Malaise—Prednisone—prostate cancer	0.000237	0.000459	CcSEcCtD
Tranexamic Acid—Abdominal pain—Etoposide—prostate cancer	0.000237	0.000459	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000237	0.000583	CbGpPWpGaD
Tranexamic Acid—Nervous system disorder—Capecitabine—prostate cancer	0.000237	0.000458	CcSEcCtD
Tranexamic Acid—Haemorrhage—Epirubicin—prostate cancer	0.000237	0.000458	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—SRC—prostate cancer	0.000236	0.000581	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000236	0.000581	CbGpPWpGaD
Tranexamic Acid—Hypotension—Docetaxel—prostate cancer	0.000233	0.00045	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—IL2—prostate cancer	0.000232	0.00057	CbGpPWpGaD
Tranexamic Acid—Loss of consciousness—Prednisone—prostate cancer	0.000231	0.000448	CcSEcCtD
Tranexamic Acid—Nausea—Estradiol—prostate cancer	0.00023	0.000445	CcSEcCtD
Tranexamic Acid—Vomiting—Mitoxantrone—prostate cancer	0.000229	0.000443	CcSEcCtD
Tranexamic Acid—Sinusitis—Doxorubicin—prostate cancer	0.000229	0.000443	CcSEcCtD
Tranexamic Acid—Convulsion—Prednisone—prostate cancer	0.000228	0.000441	CcSEcCtD
Tranexamic Acid—Visual impairment—Epirubicin—prostate cancer	0.000228	0.000441	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—STAT3—prostate cancer	0.000228	0.00056	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000227	0.000439	CcSEcCtD
Tranexamic Acid—Headache—Mitoxantrone—prostate cancer	0.000226	0.000437	CcSEcCtD
Tranexamic Acid—Hypotension—Capecitabine—prostate cancer	0.000225	0.000436	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000224	0.000553	CbGpPWpGaD
Tranexamic Acid—Arthralgia—Prednisone—prostate cancer	0.000224	0.000434	CcSEcCtD
Tranexamic Acid—Myalgia—Prednisone—prostate cancer	0.000224	0.000434	CcSEcCtD
Tranexamic Acid—Dyspnoea—Docetaxel—prostate cancer	0.000222	0.00043	CcSEcCtD
Tranexamic Acid—Discomfort—Prednisone—prostate cancer	0.000222	0.000428	CcSEcCtD
Tranexamic Acid—Eye disorder—Epirubicin—prostate cancer	0.000221	0.000428	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Etoposide—prostate cancer	0.000221	0.000427	CcSEcCtD
Tranexamic Acid—Haemoglobin—Doxorubicin—prostate cancer	0.00022	0.000426	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.00022	0.000425	CcSEcCtD
Tranexamic Acid—Flushing—Epirubicin—prostate cancer	0.00022	0.000425	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Epirubicin—prostate cancer	0.00022	0.000425	CcSEcCtD
Tranexamic Acid—Dyspepsia—Docetaxel—prostate cancer	0.000219	0.000424	CcSEcCtD
Tranexamic Acid—Haemorrhage—Doxorubicin—prostate cancer	0.000219	0.000423	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—JUP—prostate cancer	0.000217	0.000534	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—WNT4—prostate cancer	0.000217	0.000534	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ITGB3—prostate cancer	0.000217	0.000533	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000215	0.000416	CcSEcCtD
Tranexamic Acid—Asthenia—Etoposide—prostate cancer	0.000215	0.000416	CcSEcCtD
Tranexamic Acid—Dyspnoea—Capecitabine—prostate cancer	0.000215	0.000416	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Prednisone—prostate cancer	0.000215	0.000416	CcSEcCtD
Tranexamic Acid—Fatigue—Docetaxel—prostate cancer	0.000215	0.000416	CcSEcCtD
Tranexamic Acid—Angiopathy—Epirubicin—prostate cancer	0.000215	0.000415	CcSEcCtD
Tranexamic Acid—Nausea—Mitoxantrone—prostate cancer	0.000214	0.000414	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—PLAUR—prostate cancer	0.000214	0.000526	CbGpPWpGaD
Tranexamic Acid—Immune system disorder—Epirubicin—prostate cancer	0.000214	0.000413	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Epirubicin—prostate cancer	0.000213	0.000412	CcSEcCtD
Tranexamic Acid—Dyspepsia—Capecitabine—prostate cancer	0.000212	0.000411	CcSEcCtD
Tranexamic Acid—Arrhythmia—Epirubicin—prostate cancer	0.000211	0.000409	CcSEcCtD
Tranexamic Acid—Visual impairment—Doxorubicin—prostate cancer	0.000211	0.000408	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Prednisone—prostate cancer	0.000211	0.000408	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000209	0.000515	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000208	0.000403	CcSEcCtD
Tranexamic Acid—Fatigue—Capecitabine—prostate cancer	0.000208	0.000402	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—RALBP1—prostate cancer	0.000207	0.000509	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MC2R—prostate cancer	0.000207	0.000509	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—EGFR—prostate cancer	0.000207	0.000509	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Docetaxel—prostate cancer	0.000205	0.000397	CcSEcCtD
Tranexamic Acid—Diarrhoea—Etoposide—prostate cancer	0.000205	0.000397	CcSEcCtD
Tranexamic Acid—Eye disorder—Doxorubicin—prostate cancer	0.000205	0.000396	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Docetaxel—prostate cancer	0.000204	0.000394	CcSEcCtD
Tranexamic Acid—Flushing—Doxorubicin—prostate cancer	0.000203	0.000393	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Doxorubicin—prostate cancer	0.000203	0.000393	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SRC—prostate cancer	0.000202	0.000498	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—CASP3—prostate cancer	0.000201	0.000495	CbGpPWpGaD
Tranexamic Acid—Back pain—Epirubicin—prostate cancer	0.000199	0.000385	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Capecitabine—prostate cancer	0.000199	0.000385	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000199	0.00049	CbGpPWpGaD
Tranexamic Acid—Angiopathy—Doxorubicin—prostate cancer	0.000199	0.000384	CcSEcCtD
Tranexamic Acid—Dizziness—Etoposide—prostate cancer	0.000198	0.000384	CcSEcCtD
Tranexamic Acid—Muscle spasms—Epirubicin—prostate cancer	0.000198	0.000383	CcSEcCtD
Tranexamic Acid—Immune system disorder—Doxorubicin—prostate cancer	0.000198	0.000382	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Capecitabine—prostate cancer	0.000197	0.000382	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Doxorubicin—prostate cancer	0.000197	0.000382	CcSEcCtD
Tranexamic Acid—Abdominal pain—Docetaxel—prostate cancer	0.000197	0.000381	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—VEGFA—prostate cancer	0.000197	0.000485	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000196	0.000379	CcSEcCtD
Tranexamic Acid—Arrhythmia—Doxorubicin—prostate cancer	0.000196	0.000378	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—KRAS—prostate cancer	0.000195	0.000481	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Epirubicin—prostate cancer	0.000191	0.00037	CcSEcCtD
Tranexamic Acid—Abdominal pain—Capecitabine—prostate cancer	0.000191	0.000369	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PLAU—prostate cancer	0.000191	0.000469	CbGpPWpGaD
Tranexamic Acid—Vomiting—Etoposide—prostate cancer	0.000191	0.000369	CcSEcCtD
Tranexamic Acid—Anaemia—Epirubicin—prostate cancer	0.00019	0.000368	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP9—prostate cancer	0.00019	0.000468	CbGpPWpGaD
Tranexamic Acid—Dyspepsia—Prednisone—prostate cancer	0.000189	0.000366	CcSEcCtD
Tranexamic Acid—Headache—Etoposide—prostate cancer	0.000188	0.000363	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—CAV1—prostate cancer	0.000186	0.000458	CbGpPWpGaD
Tranexamic Acid—Malaise—Epirubicin—prostate cancer	0.000186	0.000359	CcSEcCtD
Tranexamic Acid—Fatigue—Prednisone—prostate cancer	0.000185	0.000358	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PENK—prostate cancer	0.000184	0.000454	CbGpPWpGaD
Tranexamic Acid—Back pain—Doxorubicin—prostate cancer	0.000184	0.000357	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Docetaxel—prostate cancer	0.000184	0.000355	CcSEcCtD
Tranexamic Acid—Muscle spasms—Doxorubicin—prostate cancer	0.000183	0.000354	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Epirubicin—prostate cancer	0.000181	0.00035	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	0.000181	0.000445	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CA—prostate cancer	0.00018	0.000442	CbGpPWpGaD
Tranexamic Acid—Asthenia—Docetaxel—prostate cancer	0.000179	0.000346	CcSEcCtD
Tranexamic Acid—Convulsion—Epirubicin—prostate cancer	0.000178	0.000345	CcSEcCtD
Tranexamic Acid—Nausea—Etoposide—prostate cancer	0.000178	0.000345	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Capecitabine—prostate cancer	0.000178	0.000344	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Prednisone—prostate cancer	0.000177	0.000343	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Doxorubicin—prostate cancer	0.000177	0.000342	CcSEcCtD
Tranexamic Acid—Anaemia—Doxorubicin—prostate cancer	0.000176	0.000341	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—GHR—prostate cancer	0.000176	0.000433	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Prednisone—prostate cancer	0.000176	0.00034	CcSEcCtD
Tranexamic Acid—Myalgia—Epirubicin—prostate cancer	0.000175	0.000339	CcSEcCtD
Tranexamic Acid—Chest pain—Epirubicin—prostate cancer	0.000175	0.000339	CcSEcCtD
Tranexamic Acid—Arthralgia—Epirubicin—prostate cancer	0.000175	0.000339	CcSEcCtD
Tranexamic Acid—Discomfort—Epirubicin—prostate cancer	0.000173	0.000335	CcSEcCtD
Tranexamic Acid—Asthenia—Capecitabine—prostate cancer	0.000173	0.000335	CcSEcCtD
Tranexamic Acid—Malaise—Doxorubicin—prostate cancer	0.000172	0.000332	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000171	0.000422	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Docetaxel—prostate cancer	0.000171	0.00033	CcSEcCtD
Tranexamic Acid—Abdominal pain—Prednisone—prostate cancer	0.00017	0.000329	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PIK3CG—prostate cancer	0.00017	0.000418	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.00017	0.000417	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NRP1—prostate cancer	0.000169	0.000415	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Epirubicin—prostate cancer	0.000168	0.000325	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—EGF—prostate cancer	0.000168	0.000413	CbGpPWpGaD
Tranexamic Acid—Loss of consciousness—Doxorubicin—prostate cancer	0.000168	0.000324	CcSEcCtD
Tranexamic Acid—Convulsion—Doxorubicin—prostate cancer	0.000165	0.000319	CcSEcCtD
Tranexamic Acid—Diarrhoea—Capecitabine—prostate cancer	0.000165	0.000319	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Epirubicin—prostate cancer	0.000165	0.000319	CcSEcCtD
Tranexamic Acid—Dizziness—Docetaxel—prostate cancer	0.000165	0.000319	CcSEcCtD
Tranexamic Acid—Myalgia—Doxorubicin—prostate cancer	0.000162	0.000314	CcSEcCtD
Tranexamic Acid—Arthralgia—Doxorubicin—prostate cancer	0.000162	0.000314	CcSEcCtD
Tranexamic Acid—Chest pain—Doxorubicin—prostate cancer	0.000162	0.000314	CcSEcCtD
Tranexamic Acid—Discomfort—Doxorubicin—prostate cancer	0.00016	0.00031	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.00016	0.000394	CbGpPWpGaD
Tranexamic Acid—Dizziness—Capecitabine—prostate cancer	0.00016	0.000309	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—IL6—prostate cancer	0.000159	0.000391	CbGpPWpGaD
Tranexamic Acid—Vomiting—Docetaxel—prostate cancer	0.000158	0.000306	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Prednisone—prostate cancer	0.000158	0.000306	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—CREBBP—prostate cancer	0.000157	0.000387	CbGpPWpGaD
Tranexamic Acid—Hypotension—Epirubicin—prostate cancer	0.000157	0.000304	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—VIP—prostate cancer	0.000157	0.000386	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GNRH1—prostate cancer	0.000157	0.000386	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—TGFB1—prostate cancer	0.000157	0.000386	CbGpPWpGaD
Tranexamic Acid—Headache—Docetaxel—prostate cancer	0.000156	0.000302	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Doxorubicin—prostate cancer	0.000156	0.000301	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—IGF1—prostate cancer	0.000155	0.000382	CbGpPWpGaD
Tranexamic Acid—Asthenia—Prednisone—prostate cancer	0.000154	0.000298	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	0.000154	0.000378	CbGpPWpGaD
Tranexamic Acid—Vomiting—Capecitabine—prostate cancer	0.000153	0.000297	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000153	0.000296	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Doxorubicin—prostate cancer	0.000153	0.000295	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000152	0.000375	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GRP—prostate cancer	0.000152	0.000374	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—LPAR1—prostate cancer	0.000152	0.000374	CbGpPWpGaD
Tranexamic Acid—Headache—Capecitabine—prostate cancer	0.000151	0.000292	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PLCB2—prostate cancer	0.00015	0.00037	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—LRP2—prostate cancer	0.00015	0.00037	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Epirubicin—prostate cancer	0.00015	0.00029	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PIK3CD—prostate cancer	0.000149	0.000367	CbGpPWpGaD
Tranexamic Acid—Nausea—Docetaxel—prostate cancer	0.000148	0.000286	CcSEcCtD
Tranexamic Acid—Dyspepsia—Epirubicin—prostate cancer	0.000148	0.000286	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—LEP—prostate cancer	0.000148	0.000364	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SERPINE1—prostate cancer	0.000147	0.000363	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CX3CL1—prostate cancer	0.000147	0.000363	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—P4HB—prostate cancer	0.000147	0.000363	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Prednisone—prostate cancer	0.000147	0.000284	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—AKT1—prostate cancer	0.000147	0.000361	CbGpPWpGaD
Tranexamic Acid—Hypotension—Doxorubicin—prostate cancer	0.000145	0.000281	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000145	0.000281	CcSEcCtD
Tranexamic Acid—Fatigue—Epirubicin—prostate cancer	0.000145	0.00028	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—HIST1H2BG—prostate cancer	0.000145	0.000356	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GRB7—prostate cancer	0.000143	0.000353	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PDE4D—prostate cancer	0.000143	0.000353	CbGpPWpGaD
Tranexamic Acid—Nausea—Capecitabine—prostate cancer	0.000143	0.000277	CcSEcCtD
Tranexamic Acid—Dizziness—Prednisone—prostate cancer	0.000142	0.000275	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000142	0.000274	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—NOS3—prostate cancer	0.000141	0.000347	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HIST1H4H—prostate cancer	0.00014	0.000344	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Doxorubicin—prostate cancer	0.000139	0.000268	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Epirubicin—prostate cancer	0.000139	0.000268	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Epirubicin—prostate cancer	0.000137	0.000266	CcSEcCtD
Tranexamic Acid—Dyspepsia—Doxorubicin—prostate cancer	0.000137	0.000265	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—JAK2—prostate cancer	0.000137	0.000337	CbGpPWpGaD
Tranexamic Acid—Vomiting—Prednisone—prostate cancer	0.000137	0.000264	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—GNG5—prostate cancer	0.000136	0.000336	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000136	0.000335	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000135	0.000332	CbGpPWpGaD
Tranexamic Acid—Headache—Prednisone—prostate cancer	0.000135	0.00026	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000134	0.00026	CcSEcCtD
Tranexamic Acid—Fatigue—Doxorubicin—prostate cancer	0.000134	0.000259	CcSEcCtD
Tranexamic Acid—Abdominal pain—Epirubicin—prostate cancer	0.000133	0.000257	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PIK3CB—prostate cancer	0.00013	0.00032	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Doxorubicin—prostate cancer	0.000128	0.000248	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000128	0.000315	CbGpPWpGaD
Tranexamic Acid—Nausea—Prednisone—prostate cancer	0.000128	0.000247	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000127	0.000246	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—INS—prostate cancer	0.000126	0.000311	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—AKT1—prostate cancer	0.000126	0.000309	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Epirubicin—prostate cancer	0.000124	0.00024	CcSEcCtD
Tranexamic Acid—Abdominal pain—Doxorubicin—prostate cancer	0.000123	0.000238	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—IGF1—prostate cancer	0.000122	0.000301	CbGpPWpGaD
Tranexamic Acid—Asthenia—Epirubicin—prostate cancer	0.000121	0.000233	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—IL2—prostate cancer	0.000119	0.000294	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTHLH—prostate cancer	0.000119	0.000293	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TGFBR1—prostate cancer	0.000119	0.000293	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—MMP2—prostate cancer	0.000118	0.000291	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKR1C3—prostate cancer	0.000117	0.000288	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PRKACB—prostate cancer	0.000116	0.000286	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Epirubicin—prostate cancer	0.000115	0.000222	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Doxorubicin—prostate cancer	0.000115	0.000222	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—THBS1—prostate cancer	0.000113	0.000279	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PPP3CA—prostate cancer	0.000113	0.000279	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ANXA1—prostate cancer	0.000112	0.000275	CbGpPWpGaD
Tranexamic Acid—Asthenia—Doxorubicin—prostate cancer	0.000112	0.000216	CcSEcCtD
Tranexamic Acid—Dizziness—Epirubicin—prostate cancer	0.000111	0.000215	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PRKCZ—prostate cancer	0.00011	0.00027	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—EP300—prostate cancer	0.000107	0.000264	CbGpPWpGaD
Tranexamic Acid—Vomiting—Epirubicin—prostate cancer	0.000107	0.000207	CcSEcCtD
Tranexamic Acid—Diarrhoea—Doxorubicin—prostate cancer	0.000106	0.000206	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PARP1—prostate cancer	0.000106	0.000261	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FGFR4—prostate cancer	0.000106	0.000261	CbGpPWpGaD
Tranexamic Acid—Headache—Epirubicin—prostate cancer	0.000105	0.000204	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CALCA—prostate cancer	0.000105	0.000258	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SRC—prostate cancer	0.000104	0.000256	CbGpPWpGaD
Tranexamic Acid—Dizziness—Doxorubicin—prostate cancer	0.000103	0.000199	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CXCL12—prostate cancer	0.000102	0.000252	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—VEGFA—prostate cancer	0.000101	0.00025	CbGpPWpGaD
Tranexamic Acid—Nausea—Epirubicin—prostate cancer	9.98e-05	0.000193	CcSEcCtD
Tranexamic Acid—Vomiting—Doxorubicin—prostate cancer	9.89e-05	0.000191	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—CXCL8—prostate cancer	9.83e-05	0.000242	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—PPARA—prostate cancer	9.79e-05	0.000241	CbGpPWpGaD
Tranexamic Acid—Headache—Doxorubicin—prostate cancer	9.74e-05	0.000188	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CASP9—prostate cancer	9.62e-05	0.000237	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PRKCQ—prostate cancer	9.33e-05	0.00023	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NGFR—prostate cancer	9.33e-05	0.00023	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—TGFB1—prostate cancer	9.31e-05	0.000229	CbGpPWpGaD
Tranexamic Acid—Nausea—Doxorubicin—prostate cancer	9.24e-05	0.000179	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—MAP3K7—prostate cancer	9.22e-05	0.000227	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CTNNB1—prostate cancer	9.07e-05	0.000223	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FGF10—prostate cancer	8.86e-05	0.000218	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ADRB2—prostate cancer	8.77e-05	0.000216	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—KRAS—prostate cancer	8.62e-05	0.000212	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—VAV3—prostate cancer	8.55e-05	0.000211	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TGFBR2—prostate cancer	8.43e-05	0.000207	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ITPR1—prostate cancer	8.29e-05	0.000204	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IGF1R—prostate cancer	7.93e-05	0.000195	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PIK3CA—prostate cancer	7.92e-05	0.000195	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	7.77e-05	0.000191	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—TP53—prostate cancer	7.67e-05	0.000189	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—LPL—prostate cancer	7.6e-05	0.000187	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PDGFRB—prostate cancer	7.53e-05	0.000185	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ITGB3—prostate cancer	7.34e-05	0.000181	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ERBB3—prostate cancer	7.12e-05	0.000175	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FGFR2—prostate cancer	7.11e-05	0.000175	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TERT—prostate cancer	6.83e-05	0.000168	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HIF1A—prostate cancer	6.53e-05	0.000161	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—AKT1—prostate cancer	6.47e-05	0.000159	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—LEP—prostate cancer	6.37e-05	0.000157	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CAV1—prostate cancer	6.31e-05	0.000155	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KDR—prostate cancer	6.24e-05	0.000154	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ESR1—prostate cancer	6.08e-05	0.00015	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—BAD—prostate cancer	5.94e-05	0.000146	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APC—prostate cancer	5.75e-05	0.000142	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CG—prostate cancer	5.75e-05	0.000142	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EGF—prostate cancer	5.68e-05	0.00014	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IRS1—prostate cancer	5.68e-05	0.00014	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GSK3B—prostate cancer	5.52e-05	0.000136	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—INS—prostate cancer	5.44e-05	0.000134	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CREBBP—prostate cancer	5.33e-05	0.000131	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IGF1—prostate cancer	5.27e-05	0.00013	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAP2K1—prostate cancer	5.09e-05	0.000125	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CD—prostate cancer	5.06e-05	0.000124	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SERPINE1—prostate cancer	5e-05	0.000123	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FGF2—prostate cancer	4.84e-05	0.000119	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NOS3—prostate cancer	4.77e-05	0.000118	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—JAK2—prostate cancer	4.64e-05	0.000114	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MDM2—prostate cancer	4.53e-05	0.000112	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ERBB2—prostate cancer	4.47e-05	0.00011	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CB—prostate cancer	4.41e-05	0.000108	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCL8—prostate cancer	4.23e-05	0.000104	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CDKN1B—prostate cancer	4.14e-05	0.000102	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CASP3—prostate cancer	4.05e-05	9.98e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL2—prostate cancer	4.05e-05	9.96e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCND1—prostate cancer	3.95e-05	9.71e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CTNNB1—prostate cancer	3.91e-05	9.62e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MMP9—prostate cancer	3.83e-05	9.43e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CDKN1A—prostate cancer	3.82e-05	9.4e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTEN—prostate cancer	3.81e-05	9.37e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EP300—prostate cancer	3.63e-05	8.94e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SRC—prostate cancer	3.53e-05	8.69e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—VEGFA—prostate cancer	3.44e-05	8.47e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—STAT3—prostate cancer	3.41e-05	8.38e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MYC—prostate cancer	3.16e-05	7.79e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TGFB1—prostate cancer	3.16e-05	7.77e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EGFR—prostate cancer	3.1e-05	7.62e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KRAS—prostate cancer	2.92e-05	7.2e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CA—prostate cancer	2.69e-05	6.61e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TP53—prostate cancer	2.6e-05	6.4e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL6—prostate cancer	2.38e-05	5.86e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKT1—prostate cancer	2.19e-05	5.4e-05	CbGpPWpGaD
